Skip to main content

Table 2 Overview of the base case results comparing AVD versus BSC

From: Early health economic evaluation of the future potential of next generation artificial vision systems for treating blindness in Germany

Costs in Euro

AVD

BSC

Incremental

Mean Costs in Euro

€189,887

€81,962

€107,925

Standard Deviation

€16,732

€12,138

€15,035

2.5% Confidence Interval

€155,538

€57,298

€77,379

97.5% Confidence Interval

€221,407

€106,697

€136,992

Effect in QALYs

AVD

BSC

Incremental

Mean QALYs

14.19

12.16

2.03

Standard Deviation

2.12

1.80

1.94

2.5% Confidence Interval

9.86

8.54

−1.70

97.5% Confidence Interval

18.48

15.66

5.87

Cost-Effectiveness

Cost per QALY gained (AVD versus BSC)

Cost per QALY gained in Euro

€53,165

Standard Deviation

€13,273,467

2.5% Confidence Interval

-€501,604

97.5% Confidence Interval

€757,628

  1. AVD Artificial Vision Device, BSC Best Supportive Care, QALY Quality Adjusted Life Year.